Surgeon Sleep Timing Tied to Risk - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Surgeon Sleep Timing Tied to Risk

Severe social jet lag among surgeons was associated with higher rates of major adverse events, independent of sleep duration, workload, and patient risk.

  • By

  • Andrea Surnit

  • June 3, 2026

  • 5 min

Share

Objective:

To evaluate the association between surgeon sleep timing and the occurrence of major adverse events in surgical patients, highlighting its potential significance.

Key Findings:
  • Major adverse events occurred in 20% of operations, indicating a significant concern for patient safety.
  • Severe social jet lag (≥2 hours) was associated with a 36% higher adjusted risk of major adverse events compared to <1 hour.
  • Surgeons with burnout exhibited higher social jet lag and midsleep time variability, suggesting a link between burnout and sleep irregularity.
Interpretation:

The study suggests a potential link between irregular sleep timing and increased risk of adverse surgical outcomes, though causality cannot be established; the correlation is noteworthy.

Limitations:
  • Only 38 of 70 eligible surgeons participated, potentially limiting generalizability and impacting the robustness of the findings.
  • Study conducted in a single geographic region, which may not reflect broader trends.
  • Residual confounding from unmeasured factors may affect results, including lifestyle factors like caffeine consumption.
Conclusion:

The findings contribute to the understanding of sleep regularity as a crucial component of sleep health and its potential impact on surgical outcomes, emphasizing the need for further research.

Original Source(s)

Surgeon Sleep Timing Tied to Risk

  • by Andrea Surnit

  • June 3, 2026

Related Content

FDA Expands Test for Gastric and Esophageal Cancers

According to Agilent Technologies, the expanded indication covers esophageal and gastric tumor types and applies to patients being considered for nivolumab or nivolumab and hyaluronidase-nvhy.

FDA monthly preview: Key September decisions to watch

Several FDA decisions across multiple specialties are expected this month.

Same‐admission cholecystectomy linked to lower pancreatitis recurrence

Same‐admission cholecystectomy was associated with fewer recurrent episodes of gallstone‐related acute pancreatitis and fewer biliary complications than endoscopic retrograde cholangiopancreatography alone or no intervention in a nationwide Swedish cohort.